Minimally Invasive Heart Surgery for Obese Patients.
Obesity is one of the most common comorbidities in cardiac surgery patients, with over 40% of patients undergoing cardiac operations in the United States having a BMI above 30. For obese patients, the surgical approach — full sternotomy versus minimally invasive — takes on particular significance. Sternotomy in obese patients carries higher rates of wound infection (including deep sternal wound infection, a life-threatening complication), prolonged ventilation, and delayed mobilization. Minimally invasive approaches that avoid sternotomy can reduce these obesity-specific risks. However, minimally invasive cardiac surgery in obese patients presents its own technical challenges. Chest wall thickness, limited intercostal spaces, and difficult access angles can make minimally invasive valve surgery or robotic-assisted CABG technically demanding. Not all surgeons or programs are equipped to perform minimally invasive cardiac surgery in patients with BMI above 35, and the learning curve for these approaches in obese patients is steeper than in normal-weight individuals. The decision between full sternotomy and a minimally invasive approach in an obese patient requires a surgeon with experience in both techniques and an honest assessment of which approach is safest for the individual patient's body habitus.
What the evidence shows.
A 2022 meta-analysis in the Annals of Thoracic Surgery comparing minimally invasive mitral valve surgery in obese (BMI 30+) versus non-obese patients found no significant difference in mortality, conversion to sternotomy, or major complications, suggesting that minimally invasive approaches are safe in selected obese patients when performed by experienced surgeons. Sternal wound infection rates with full sternotomy in obese patients range from 3-8% (vs 1-2% in normal weight), with deep sternal wound infection rates of 2-4% — a complication carrying 10-25% mortality. Obesity is an independent risk factor for prolonged ventilation (OR 1.5-2.0) and ICU length of stay after sternotomy. Robotic-assisted CABG data in obese patients is limited but shows feasibility in patients with BMI up to 40 when performed at experienced centers.
Current recommendations.
Current expert consensus recommends: (1) consider minimally invasive approaches for obese patients when technically feasible, particularly for isolated valve surgery; (2) surgeon experience with minimally invasive techniques in obese patients should guide approach selection — an experienced sternotomy surgeon may deliver better outcomes than an inexperienced minimally invasive surgeon in a difficult body habitus; (3) aggressive perioperative glucose control (targeting blood sugar under 180 mg/dL), prophylactic negative-pressure wound therapy, and early mobilization are essential to reducing sternal wound complications in obese patients who undergo sternotomy; (4) weight loss prior to elective cardiac surgery should be encouraged when time permits, as even 10-15 pounds of weight reduction can improve surgical access and reduce wound complications.
Why this matters for your decision.
Obese patients are at significantly higher risk of sternal wound complications, which are among the most devastating complications in cardiac surgery. A second opinion can determine whether a minimally invasive approach is feasible for the specific patient, potentially avoiding sternotomy altogether — and if sternotomy is necessary, can ensure the surgical team has a comprehensive plan to mitigate obesity-specific risks including wound infection prophylaxis, ventilatory management, and early mobilization.
Need help with this decision?
Our Heart Team evaluates your specific situation with AI-augmented analysis and dual-physician review.